Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

15
Aveo Pharmaceuticals, Vodafone Pile into Wednesday’s 52-Week Low Club

2018-07-18 247wallst
July 18, 2018: Here are four stocks trading with heavy volume among 72 equities making new 52-week lows in Wednesday’s session. On the NYSE advancers led decliners by about 1.18 to 1 and on the Nasdaq, advancers led decliners by about 1.382 to 1.
VOD VOD VODPF AVEO HK AVP

26
Top Analyst Upgrades and Downgrades: Avon, Broadcom, CDW, CSX, Goldman Sachs, Starbucks, Twitter, Under Armour, Windstream and More

2018-07-18 247wallst
Stocks were looking for direction on Wednesday with a fairly light day on economic data. Investors have had less faith and have seen lower rewards from buying the dips than in prior years. Many of those same investors have also been concerned about how they want their investments positioned ahead of the midterm elections, into international trade concerns and also for the longer term, into 2019 and beyond.
WFCNP UAA COLM AVP CDW WFC.PRL WFC.PRJ EXR FPI BMO WFC.PRT FPI.PRB WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN TWTR AVGO CF CDWHF CSX WFC.PRY WFC.PRX WFC.PRW WFC.PRV WFC WFC.WS BMO UA BWA FHN TRI SBUX BRCM FHN.PRA

12
Goodyear, Vodafone Slink into Tuesday’s 52-Week Low Club

2018-07-17 247wallst
July 17, 2018: Here are four stocks trading with heavy volume among 68 equities making new 52-week lows in Tuesday’s session. On the NYSE advancers led decliners by about 1.34 to 1 and on the Nasdaq, advancers led decliners by about 1.38 to 1.
GT VOD VOD VODPF HK AVP

1
AVP / Avon Products, Inc. null

2018-07-13 sec.gov
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"[email protected],"!O8FH-/#PO3&EN96%R:7IE9" [email protected],S,R M,# O3R Q,2]%(#(X,[email protected],B]4(#,R.3 [email protected]@6R [email protected],30X73X^#65N M9&]B:@[email protected](" @(" @(" @(" @(" @(" @#0HQ-B P(&]B:@T\/"]$96-O9&50 M87)M7!E+UA2968O5ULQ(#(@,5T^/G-T('$UW8&)D:&&2 E#(Q,_QEW_P<(, "[email protected][email protected] M#0IE;F1S=')E86T-96YD;V)J#7-T87)T>')[email protected]*, T*)25%3T8-"B @(" @ M(" @#0HQ.2 P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22 X,R],96YG [email protected]@-CDO4R T.
AVP

1
AVP / Avon Products, Inc. null

2018-07-13 sec.gov
Document June 7th, 2018 Ms. Melissa
AVP

1
AVP / Avon Products, Inc. null

2018-07-13 sec.gov
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C<@,"!O8FH-/#PO3&EN96%R:7IE9" [email protected],S$X M,38O3R [email protected],C
AVP

16
Broadcom, American Airlines Drop into Thursday’s 52-Week Low Club

2018-07-12 247wallst
July 12, 2018: Here are four stocks trading with heavy volume among 63 equities making new 52-week lows in Thursday’s session. On the NYSE advancers led decliners by about 1.53 to 1 and on the Nasdaq, advancers led decliners by about 1.42 to 1.
AAL AVGO HK AVP BRCM

1
Will Avon's (AVP) Transformation Plan Aid a Turnaround?

2018-07-11 zacks
Avon Products, Inc. (AVP - Free Report) is out of investors’ good books for a while now as the company is grappling with weak Representatives growth for the last few quarters. In fact, this has largely impacted the company’s top line, which lagged estimates in five of the trailing seven quarters. The company has also missed earnings estimates in eight of the last 11 quarters. Dismal surprise history largely weighed on this Zacks Rank #4 (Sell) company’s price performance.
OLLI LMT AVP MED ADM

10
American Airlines, Avon Products Plummet into Wednesday’s 52-Week Low Club

2018-07-11 247wallst
July 11, 2018: Here are four stocks trading with heavy volume among 63 equities making new 52-week lows in Wednesday’s session. On the NYSE decliners led advancers by about5 2.5 to 1 and on the Nasdaq, decliners led advancers by about 1.87 to 1.
FPI.PRB IDRAW AAL IDRA AVP FPI

31
Avon Products, Nevro Plunge into Tuesday’s 52-Week Low Club

2018-07-10 247wallst
July 10, 2018: Here are four stocks trading with heavy volume among 31 equities making new 52-week lows in Tuesday’s session. On the NYSE advancers and decliners were dead even and on the Nasdaq, decliners led advancers by about 1.4 to 1.
RGLS NVRO MDXG AVP

15
Exclusive: Amazon to tap Brazil beauty obsession with cosmetics partners

2018-06-14 channelnewsasia
Amazon.com Inc is recruiting major Brazilian cosmetics firms Grupo Boticario and Natura Cosmeticos SA to sell via the logistics platform it is developing in Brazil, three people familiar with talks told Reuters, making an early play for the world's fourth-largest beauty market.
REV NUACF AVP AZUL

15
Exclusive: Amazon to tap Brazil beauty obsession with cosmetics partners

2018-06-14 reuters
SAO PAULO (Reuters) - Amazon.com Inc (AMZN.O) is recruiting major Brazilian cosmetics firms Grupo Boticario and Natura Cosmeticos SA (NATU3.SA) to sell via the logistics platform it is developing in Brazil, three people familiar with talks told Reuters, making an early play for the world’s fourth-largest beauty market.
REV NUACF AVP AZUL

16
H&R Block, Avon Products Dive Wednesday’s 52-Week Low Club

2018-06-13 247wallst
June 13, 2018: Here are four stocks trading with heavy volume among 48 equities making new 52-week lows in Wednesday’s session. On the NYSE decliners led advancers by about 1.78 to 1 and on the Nasdaq, decliners led advancers by about 1.14 to 1.
HMY HRB VOD VOD VODPF AVP HGMCF

62
Avon Products, Globalstar Drop into Tuesday’s 52-Week Low Club

2018-06-12 247wallst
June 12, 2018: Here are four stocks trading with heavy volume among 41 equities making new 52-week lows in Tuesday’s session. On the NYSE decliners led advancers by about 1.01 to 1 and on the Nasdaq, advancers led decliners by about 1.2 to 1.
HMY GSAT NGD AVP NGDAF NGD HGMCF

15
Avon Products Down 43% in 3 Months: What's Hurting the Stock?

2018-06-12 zacks
Avon Products, Inc. (AVP - Free Report) has been losing sheen due to sluggish Active Representatives growth in the last few quarters. This, in turn, is affecting the company’s top-line performance and profitability. Apparently, the company has lagged earnings estimates in eight of the last 11 quarters. Also, sales missed estimates in five of the last seven quarters. Consequently, this Zacks Rank #4 (Sell) stock has plunged 43% in the past three months, significantly wider than the industry’s decline of mere 1.
IPAR HELE OLLI WTR AVP UTX

AVP: Avon Products Analysis and Research Report

2018-05-28 - Asif

Business Avon Products is a global manufacturer and marketer of beauty and related products. The company commenced operations in 1886 and were incorporated in the State of New York on January 27, 1916. The company conduct its business in the highly competitive beauty industry and compete against other consumer packaged goods ("CPG") and direct-selling companies to create, manufacture and market beauty and non-beauty-related products. The company's product categories are Beauty and Fashion & Home. Beauty consists of skincare, fragrance and color (cosmetics). Fashion & Home consists of fashion jewelry, watches, apparel, footwear, accessories, gift and decorative products, housewares, entertainment and leisure products, children’s products and nutritional products. The company's business is conducted primarily in one channel, direct selling. The company's reportable segments are based on geographic operations in four regions: Europe, Middle East & Africa; South Latin America; N...

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to AVP / Avon Products, Inc. on message board site Silicon Investor.

Avcorp Industries Inc. AVP-TSE
CUSIP: 054303102